ResoTher Pharma A/S: cash_and_equivalents

Value{"amount": 4510000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2019-12-31)
Statuscurrent
EntityResoTher Pharma A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:5493004IM45YLQPU2R19:2021-12-31
Retrieved: 2026-08-24T01:18:56.525325+02:00
Raw response sha256: e4adb54f5c3a5d10fb92c778497f2c05…
Cite as: FACTANKER, https://factanker.com/fact/29b3e197-b815-4cda-964e-b7ea4204b461

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies